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1  |  INTRODUC TION
One of the key functions of blood coagulation is to produce a fibrin 
clot to stem bleeding after injury. The protease responsible for fibrin 
production is thrombin, which has many other functions including 
the activation of platelets but also the activation of anticoagulant 
systems (protein C) and inhibition of fibrinolysis (via the thrombin 
activatable fibrinolysis inhibitor).1 Fibrin is produced in a matter of 
minutes by thrombin- mediated cleavage of fibrinogen, a protein with 
a very high concentration in the blood, second only to albumin and 
the immunoglobulins. Once converted from highly soluble fibrino-
gen to fibrin, the protein rapidly generates a network that contains 
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Abstract
Polymeric fibrin displays unique structural and biomechanical properties that con-
tribute to its essential role of generating blood clots that stem bleeds. The aim of this 
review is to discuss how the fibrin clot is formed, how protofibrils make up individual 
fibrin fibers, what the relationship is between the molecular structure and fibrin bio-
mechanical properties, and how fibrin biomechanical properties relate to the risk of 
thromboembolic disease. Fibrin polymerization is driven by different types of bonds, 
including knob- hole interactions displaying catch- slip characteristics, and covalent 
crosslinking of fibrin polypeptides by activated factor XIII. Key biophysical proper-
ties of fibrin polymer are its visco- elasticity, extensibility and resistance to rupture. 
The internal packing of protofibrils within fibers changes fibrin biomechanical behav-
ior. There are several methods to analyze fibrin biomechanical properties at different 
scales, including AFM force spectroscopy, magnetic or optical tweezers and rheom-
etry, amongst others. Clinically, fibrin biomechanical characteristics are key for the 
prevention of thromboembolic disorders such as pulmonary embolism. Future studies 
are needed to address unanswered questions regarding internal molecular structure 
of the fibrin polymer, the structural and molecular basis of its remarkable mechanical 
properties and the relationship of fibrin biomechanical characteristics with thrombo-
embolism in patients with deep vein thrombosis and ischemic stroke.
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pores for the accommodation of cells, and fibers that branch and 
anchor this matrix to the injury site.2,3 Thus, blood contains a sys-
tem that can trigger instant formation of a temporary matrix to stem 
bleeding and initiate tissue repair responses.
The fibrous matrix generated by fibrin has important biomechan-
ical characteristics. These properties, which include elastic and vis-
cous characteristics as well as extensibility, stiffness, and resistance 
to rupture, are important for its interaction with cells during wound 
healing.4 Furthermore, fibrin biomechanics are crucial for the ability 
of blood clots to withstand disruption due to movement and other 
mechanical stresses. However, the relevance of fibrin biomechanical 
properties for thrombosis and thromboembolic disorders is less well 
understood.
In this review, we discuss how the fibrin matrix is formed from 
fibrin monomers including the types of bonds and forces that control 
this process. Then we consider what is known regarding the internal 
structure of fibrin fibers, and the implications of this structure for 
fibrin biomechanical characteristics. Next specific rheological prop-
erties are reviewed in detail, including strength of fibrin and its fi-
bers, their elasticity and viscous properties, the extensibility of fibrin 
fibers and a process called strain hardening that is a typical charac-
teristic of fibrin. Finally, we discuss rupture of fibrin fibers or clots, 
and the clinical relevance of fibrin biomechanical characteristics for 
hemostasis and thrombosis, including thromboembolic disorders.
2  |  FORMATION OF PROTOFIBRIL S AND 
PROTOFIBRIL PACKING IN FIBRIN FIBERS
Thrombin, which is generated by the activated coagulation pathway, 
cleaves fibrinopeptide A and B from fibrinogen to initiate fibrin clot 
formation. As a result, knobs ‘A’ and ‘B’ on the N- termini of the α- 
and β- chains, respectively, become exposed and bind the ‘a’ and ‘b’ 
holes in the C- terminal domains of the γ- and β- chains respectively in 
adjacent fibrin(ogen) molecules via noncovalent knob- hole interac-
tions (Figure 1A– C).5 Thus, the so far soluble fibrinogen turns into fi-
brin, which aggregates and forms the fibrin network. Much is known 
about the molecular detail of bond formation, yet the exact process 
of how these interactions govern the internal structure of fibers, and 
develop into a 3D network, is still not fully understood.
2.1  |  Bonds in fibrin
The noncovalent knob- hole bonds are essential for fibrin polym-
erization since a fibrin mutant with non- functional A and B knobs 
showed no signs of polymerization whatsoever.6 Among the knob- 
hole bonds, the ‘A:a’ knob hole interaction is the most significant and 
shows the largest binding strength.7 Absence of fibrinopeptide A 
cleavage in fibrin from a patient with homozygous dysfibrinogenemia 
impaired polymer formation,8 while polymerization was completely 
abolished in a murine model with mutations in the fibrinopeptide 
A cleavage site,9 indicating the importance of the A:a interaction in 
driving fibrin polymerization. The strength of A:a knob- hole interac-
tions change with tensile force, showing ‘catch- slip’ bond behavior. 
First the bond strengthens with increasing tensile strain, as a move-
able flap on the γ- nodule closes in on hole ‘a’.10 This ‘catch’ charac-
teristic may play an important role in early protofibril formation. The 
bond next turns into a ‘slip’ state above approximately 40 pN ten-
sile force resulting in the dissociation of the knob- hole bond.11 ‘B:b’ 
knob- hole bonds are 6– 8 times weaker than ‘A:a’.12 Fibrinopeptide B 
cleavage is delayed in time compared with fibrinopeptide A and has 
been reported to enhance lateral assembly of fibrin fibers.13
During protofibril formation, γ- γ interactions occur across the 
D:D interface of adjacent fibrin monomers. Once activated by 
thrombin, factor XIII crosslinks this interface forming two anti- 
parallel γ- γ bonds in the first few minutes of clotting.14 There has 
been some debate if γ- γ crosslinks form in longitudinal15,16 or trans-
verse17 direction. Recent AFM studies together with molecular sim-
ulation support the longitudinal theory.18
The C- terminal part of the α- chain extends significantly from 
the D- region forming the αC- region (Figure 1A). Bonds between the 
αC- regions connect protofibrils laterally, providing a zipper or Velcro 
effect along the length of the fibrin fiber (Figure 1D). The αC- region 
consists of an unstructured flexible αC- connector (between resi-
dues α221- 391) and a compact globular αC- domain (α392- 610).19,20 
In fibrinogen, the αC- region shows a compact conformation,21 and 
either folds back, binding the E- region in the presence of fibrino-
peptide B,22 or detaches from the E- region and shows a string- like 
form with a globule at the end.21 Following the cleavage of fibrino-
peptides, the αC- region detaches, extends, becomes more flexible 
(Figure 1B),21 and forms intramolecular interactions with αC- regions 
of adjacent fibrin molecules.22 These interactions are thermodynam-
ically driven23 between β- sheet structures via β- hairpin swapping.24
A fibrin network still forms from fibrinogen with an αC- region 
partially truncated at residue 251,25 however this α251 truncated 
variant results in a denser network containing thinner fibers and 
more branchpoints.26 Of note, physiological low molecular weight fi-
brinogen metabolites are present in vivo,27 where either one (LMW) 
or both (LMW') Aα- chains are truncated at various places.28 The 
presence of the αC- region results in thicker fibers by reducing the 
threshold length of protofibrils for lateral aggregation but it does 
not change the basic structure of protofibrils, thus the αC- region 
likely has a kinetic effect on the lateral assembly of protofibrils.21 A 
recent study from our lab found that the absence of the αC- domain 
(α390 truncation) leads to thinner, highly branched fibers resulting 
in reduced clot firmness, whereas abolishing the complete αC- region 
including the globular domain and the connector region (α220 trun-
cation) impairs longitudinal growth of protofibrils and results in clots 
with even lower firmness and a highly abnormal network structure 
with stunted fibers and a severely reduced resistance to fibrinoly-
sis.29 Thus, besides the kinetic effect on fibrin assembly and lateral 
aggregation, the αC- region has important roles in clot formation in-
cluding longitudinal fibrin fiber growth and clot stability.
Like for γ- γ interactions, activated factor XIII crosslinks the 
αC interactions too, yet these crosslinks form in a later phase of 
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clotting.14 Crosslinking of the αC- region results in more rapid fiber 
formation and thicker, straighter fibers.30 Thus, even though α- chain 
crosslinks mainly form in later phases of clotting, they likely have a 
complementary role in protofibril assembly. Possibly αC crosslinks 
pull the protofibrils closer to one another, increasing the density of 
the fiber and allowing more protofibrils to laterally assemble into 
thicker fibers.
2.2  |  Protofibril structure
Structural transitions during the formation of fibrin fibers and net-
work were first visualized by electron microscopy (EM) which dem-
onstrated two stages of assembly. The prominent process in the first 
phase involves aggregation of fibrin monomers into half- staggered 
double stranded structures called protofibrils via knob- hole bonds 
(Figure 1C).31 In the second phase, protofibrils align in parallel and 
aggregate laterally forming fibrin fibers (Figure 1D) coinciding with 
the gelation and generation of a fiber network.32
EM provides details about the structure of the (proto)fibrils, but 
may miss intermediate structures with short lifetime during early 
stages of polymerisation.33 One such structure is suggested in the 
Y- ladder model: fibrin(ogen) monomers can bind via only one A:a 
knob- hole bond, resulting in Y- ladder like structures (Figure 1E). This 
is an intermediate state before both A:a knob- hole bonds form, gen-
erating straight, double stranded protofibrils. In this intermediate 
state an extensive network of thin, frequently branching long poly-
mers can form (Figure 1F), which collapse into a main fiber via lateral 
F I G U R E  1  Early formation of fibrin. (A) Schematic representation of the fibrinogen monomer. The N- terminal of the pairs of polypeptide 
chains (α, β, and γ) are connected via disulfide bonds in the central E- region and twist around each other to form a coiled coil. The C- terminal 
region of the β- and γ- chains forms the globular D- region at the side of the molecule, which includes ‘hole A’ and ‘hole B’. The C- terminal of 
the α- chain folds back to the coiled coil and forms the αC- region, composed of an αC- connector and αC- domain. (B) Fibrin monomer. Once 
fibrinopeptides are cleaved, knobs A and B becomes exposed, and the αC- region extends. (C) Double stranded protofibrils form, as fibrin 
monomers bind to each other via knob- hole interactions. (D) Interconnecting protofibrils. Red crosses represent covalent crosslinks made by 
FXIII on the D:D interface, and multiple crosslinks between the αC- regions. (E) Y- ladder model: fibrin(ogen) monomers can form intermediate 
Y- ladder structures when only one fibrinopeptide- A is cleaved. (F) Highly branched structure, containing both Y- ladder and double stranded 
structures. αC- regions are not included here for clarity
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interactions. This collapse increases fiber thickness rapidly, reduces 
the frequent branching and leads to a lower number of fibers in the 
network.33 However, there is yet no direct structural evidence for 
the Y- ladder model. Recent AFM images showed early stages of po-
lymerization34 and protofibrils were interpreted later as frequently 
branching structures possibly resembling the structures proposed by 
the Y- ladder model.35 Although speculative, intra- protofibril branch-
ing can be an important consequence of this model, as protofibrils 
within the fibers can also be interconnected via such branching thus 
via A:a knob- hole bonds and not just via lateral interactions.35
2.3  |  Internal structure of fibrin fibers
As a result of the clotting process, fibrin fibers and the network are 
formed. The fibrin 3D network builds at very early stages of clotting 
(even before the formation of mature fibers),35 thus individual fibers 
are hard to isolate and less is known about the inner structure of 
fibrin fibers: how protofibrils are connected or packed within a fiber, 
which bonds bear the load upon mechanical perturbance and which 
events lead to fiber rupture.
We know that the internal structure of fibrin fibers is porous 
and protofibrils within the fibers are not tightly packed.36 The in-
ternal structure of fibers can be revealed by scattering techniques 
using visible light (turbidimetry and fibrinography), neutrons (small 
angle neutron scattering (SANS)) or X- ray (small- angle X- ray scatter-
ing (SAXS)) for even smaller details. SAXS shows a long range axial 
(longitudinal) packing order along fibrin fibers around 22.5 nm dis-
tance,37 corresponding to the distance between the globular D- and 
E- regions of fibrin(ogen) monomers. These 22.5 nm repeats are also 
present as a band pattern on fibrin fibers on electron microscopy im-
ages.38 However, only a shortrange and weak lateral (or radial) order 
of around 13 nm39 and 18 nm40 was found, indicating that fibrin fi-
bers have less ordered packing laterally than axially. Turbidimetry 
and fibrinography are multiwavelength scattering methods op-
timized to reveal detail about the protein density and protofibril 
content of fibrin fibers.37,41,42 Different parameters may impact on 
protein density of the fibers: increasing thrombin concentrations 
decrease protein density, and clots of the γA/γ’ splice variant of 
fibrinogen also result in less dense fibers.43 Functionally, reduced 
protofibril packing in fibers results in a decreased clot stiffness.43 In 
addition to the scattering methods, lateral atomic force microscopy 
experiments showed fiber stiffness to decrease with increasing fiber 
diameter, suggesting that protein density of fibers decreases with 
increasing fiber diameter.44
3  |  FIBER STRETCHING AND RHEOLOGY
The mechanical properties of fibrin evolved so that fibrin fulfils its 
main physiological role, i.e. to be strong enough to seal wounds and 
flexible to prevent rupture. As fibrin is the scaffold of blood clots, it 
plays an important role maintaining this structural and mechanical 
integrity. Clot mechanical behavior involves interplay between the 
structure of the network including the arrangement of fibrin fibers 
and the fiber branchpoints, and mechanical behavior of fibrin itself.
3.1  |  Measures of fibrin biomechanical properties
Even though fibrin is a mesh of interconnected fibers, and thus 
individual fibers are hard to isolate, the mechanical properties of 
individual fibrin fibers can be measured using an atomic force mi-
croscopy (AFM) and optical fluorescence based method.45 Fibers 
can be deposited across microwells of a striated substrate, then 
pulled sideways with an AFM cantilever. The stress exerted on the 
fiber is calculated from the lateral deflection of the cantilever and 
the stress- strain behavior of the fiber analysis (Figure 2A). The slope 
of the stress- strain curve is the stiffness, or elastic modulus of the 
fiber at a given strain. The higher the stiffness, the more stress is 
required for a given elongation. Further parameters can be meas-
ured, such as extensibility of the fiber (maximal amount of strain be-
fore rupture), maximal force or maximal stress needed for rupture. 
Viscoelastic properties can be analyzed by following fiber behavior 
upon release: if the stress- strain curve returns on the same trajec-
tory upon release as when it was pulled and no hysteresis is present 
between the pull and release curves, the behavior is elastic, the fiber 
structure is fully recovered, and no energy is lost. However, if the 
curve follows a different path upon release and a hysteresis, or lag, 
appears between the pull and release curves, the behavior is par-
tially viscous, and some of the energy was dissipated by structural 
transitions (Figure 2A). In some cases, the structure does not fully 
recover. The elastic limit is the maximal strain where no energy is 
dissipated, and the mechanical response is still purely elastic.
Oscillatory tests can be used in rheology to describe the visco-
elastic behavior of a material. Storage (or elastic) modulus G', in phase 
with the applied shear deformation is a measure of the purely elastic 
behavior, while the component out of phase, the loss (or viscous) 
modulus G" is a measure of viscous behavior (Figure 2B). Storage 
modulus is used as a measure of clot stiffness.46 This parameter is 
related and convertible to stiffness (or Young's modulus) Y and bulk 
modulus K, but while G' is measured in shear deformation (force 
causing deformation parallel to the applied stress), Y is measured 
at normal deformation (tensile/compressive force causing deforma-
tion perpendicular to the applied stress) and uniaxally (in one direc-
tion only). The elastic and viscous moduli can also be analyzed with 
micro- rheometer devices, where passive thermal fluctuations of the 
embedded beads,47 or optical48 or magnetic forces induce controlled 
motion of the bead, informs us about viscoelastic behavior (G' and 
G")49,50 (Figure 2C). An AFM- based nanorheology method provides 
another useful approach for the analysis of fibrin elastic and viscous 
properties at the micrometer scale.51
TEG and ROTEM are rheometry- based assays that are widely 
used in clinical practice.52 These oscillatory tests measure numerous 
parameters (Figure 2D), from which the maximal amplitude reached 
during the clotting process (also called maximal clot firmness) is 
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closely related to stiffness. However, the data are presented in rela-
tive arbitrary units (amplitude of movement as the result of mechan-
ical coupling) and are thus hard to relate to quantitative parameters 
of stiffness such as Young's (Y) or storage moduli (G').
3.2  |  Fibrin extensibility and strain stiffening
Probably the most surprising mechanical property of fibrin is its high 
extensibility even though fibers are straight structures: fibrin net-
works only break at approximately 250% strain.53,54 Straight fibers 
are visible using confocal microscopy.48,55 A recent study showed 
that fibrin fibers have inherent tension as a result of further polym-
erization once the initial network structure has formed, and are ex-
tended approximately 23% over their equilibrium length they would 
have if isolated,56 suggesting that fibers are not only straight, but 
also prestrained. However, bulk measurements show that fibers are 
not completely straight but straightened by up to 25% shear strain of 
the whole clot, and fibers only start to align in the direction of stress 
above 25% shear strain.54,57 Fibers appear less straight on electron 
microscopy images than confocal microscopy29 and fibers appear 
less straight in uncrosslinked clots.30
Strain stiffening is a typical behavior of filamentous biological 
polymers58 and involves complex interplay of entropic and enthal-
pic elasticity: low strain mechanical behavior is dominated by entro-
pic behavior, when thermal undulations are pulled out decreasing 
the degree of disorder, the entropy,58 while enthalpic behavior 
dominates at high strains when the filament backbone is stretched 
leading to actual bonds being pulled, thus increasing enthalpy, the 
internal energy.59 Strain stiffening is an increase in stiffness of a (bio)
material upon transition from the flexible entropic to the more rigid 
enthalpic regime, improving the mechanical integrity of the material. 
In bulk measurements, fibrin networks show two strain stiffening 
regimes: one under 25% strain, and one above 25%.54,60 Initial strain 
stiffening, occurring at network level under 25% strain may originate 
from minor straightening of fibrin fibers, as the small thermal fluc-
tuations of fibers are pulled out (decreasing the entropy) and fibers 
start to be pulled (decreasing the enthalpy). Yet, strain stiffening be-
tween 25% and 250% strain cannot arise from fiber straightening as 
by then fibrin fibers are already straight, thus it likely originates from 
the mechanical properties and internal structure of individual fibrin 
fibers. Altogether, the mechanical behavior of the network is largely 
determined by the mechanical behavior of individual fibrin fibers, 
yet changes at network level, especially at low (<25%) strains also 
F I G U R E  2  Methods used to measure fibrin biomechanical 
properties and resultant parameters. Red color represents fibrin 
sample (in method) and the parameters measured (in result). 
(A) Lateral fiber pulling using atomic force microscopy (AFM). 
Individual fibrin fibers form across microwells of a striated 
substrate and are pulled with the AFM cantilever. The stress- 
strain behavior of the fiber is followed, where stress is calculated 
from the lateral deflection of the cantilever and strain from the 
Y- position. Low and high strain stiffness (modulus 1 and 2) are 
estimated as the slope of the linear part of the curve. Extensibility 
is the maximal strain a fiber can be elongated to before rupture. 
The clearly elastic behavior at low strains (elastic recovery, light 
blue) becomes viscoelastic at higher strains (viscoelastic, purple 
curve) as hysteresis appears between the pull and release curves. 
(B) Oscillatory test in rheology. Sample is placed between two 
plates and oscillatory strain is applied on one of the plates. If 
viscous behavior is present, a phase shift (δ) can be detected 
between the applied shear strain (black curve) and the resultant 
shear stress (blue curve). Complex shear modulus (G*) is calculated 
as the ratio of the maximal amplitude of the shear stress and 
maximal amplitude of shear strain. G', which is ‘in phase’ with 
the applied shear stress is the storage or elastic modulus, while 
G", which is ‘out of phase’ is the loss or viscous modulus. (C) 
Microheometer. During passive rheology measurements, constant 
or intermittent force (F) is applied on the microbead, embedded 
in the fibrin network. The motion of the bead is tracked and used 
to calculate storage modulus (G') and loss modulus (G") based on 
the method of Evans et al.98 These moduli can be calculated for 
a frequency range (ω), limited by measurement time (lower limit) 
and time resolution of the detection (upper limit). Oscillation mode 
works on the same principle as shown for rheology: oscillatory 
force is applied and G' and G" are calculated from G*. (D) ROTEM. 
An oscillating pin is immersed in a cup filled with the sample. As 
the sample clots, it mechanically couples the pin and the cup, thus 
altering the movement of the oscillating pin. The measure of the 
coupling is detected as amplitude signal and followed along the 
clotting (and lysis) process. Parameters measured: CT (clotting 
time, time from activation until 2 mm amplitude is reached), CFT 
(clot formation time, timeframe between 2 and 20 mm amplitudes) 
α angle (tangential curve at 2 mm amplitude point, measure of 
the kinetics of clotting) MA (maximal amplitude, measure of the 
firmness of the formed clot)
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play a role. Besides, fibrin clot stiffness is orders of magnitude lower 
than expected using a model of rubberlike elasticity, considering the 
branchpoint density and the straight conformation of fibers,61 and 
possibly has intrafiber origin.
Single fiber pulling experiments show large extensibilities, similar 
to or slightly higher than that at network level: fibers can be elon-
gated up to 300%– 400% of their original length before rupture.45 
The elastic modulus of fibrin fibers is typically below 10 MPa,62,63 
similar to a silicone rubber, or elastin or resilin fibers, where unfold-
ing of an amorphous domain results in rubberlike elasticity, but much 
lower than for actin or collagen for example, where highly regular 
structures are extended.64 Furthermore, single fibrin fibers show 
strain- stiffening.63,65,66
Several studies investigated structural origins of high fibrin fiber 
extensibility and strain stiffening. A worm- like chain (WLC) model fits 
the stress- strain behavior of individual fibrin fibers well63 suggesting 
that the initial elastic response has an entropic origin.67 This arises 
from the flexible polymer chain randomly fluctuating and adopt-
ing an equilibrium conformation and hence length, usually termed 
persistence length. If force is applied, random fluctuations are pro-
gressively restricted as chains elongate. At greater extensions, en-
thalpic bond stretching (as a simple spring) begins to dominate, and 
eventually fiber stiffening becomes significant. The WLC model sug-
gests that the structure which bears the load at low strains is highly 
flexible with short persistence length.58 The unstructured fibrin αC- 
region, which interconnects protofibrils within the fiber is a good 
candidate for this highly extensible entropic response63 and molec-
ular modelling supported the key contribution of αC- regions in fibrin 
stress- strain behavior.68 This is further supported by data showing 
that shortening of the αC- region reduces fibrin extensibility.69 Clots 
made with α251 fibrin showed decreased storage modulus (G’) and 
increased tangent modulus (G"/G') indicating that α251 clots are less 
stiff and prone to plastic deformation.26
Fibrin fibers showed elastic stress- strain behavior (full recov-
ery with no energy loss) below 100% strain45 on a sub- millisecond 
timescale, which is too short for protein refolding,70 suggesting 
that structural transitions taking place during stretching are quickly 
and fully recoverable, pointing to an origin in the unstructured αC- 
region. Further supporting these single fiber data, fibrin networks 
showed elastic behavior at lower strain, while viscous behavior 
mainly occurred at higher strain in the stiffening regime, not long 
before network failure.47 However, another study showed viscous 
behavior of individual fibers already at low (<110%) strain, or even 
below 50% strain for fully crosslinked fibers with a combination of 
fast (~2s) and slow (~52 s) stress relaxation.66 This suggests that 
different processes like refolding and structural transitions other 
than stretching of the disordered αC- region may also contribute to 
the mechanical behavior of fibrin fibers and network. This could in-
clude α- helix to β- strand transition of the coiled coils68,71 or partial 
unfolding of the γ- chain C- terminal domain.64,72 A previous study 
has observed α- helix to β- strand transition in clots,73 which showed 
spatial heterogeneity74 suggesting non- homogeneous strain distri-
bution in the clots. Energy dissipation and increased stiffness, both 
observed in fibrin at high strains, are characteristic for α- helix to 
β- strand transitions.75
The mechanical behavior of fibrin likely involves complex inter-
play between the reported structural transitions.68,76 A recent study 
combined shear rheology with small angle X- ray scattering (SAXS) 
following the structural transitions happening at increasing shear 
strains. The 22.5 nm monomer length is unchanged at strains up to 
100% indicating that the level of the spatial order was maintained,54 
suggesting that longitudinally bonded fibrin monomers do not un-
fold below 100% strains, however αC- regions binding laterally can 
uncoil.54 An earlier paper showed that even though the monomer 
length is maintained, the structural order decreases, possibly due 
to coiled- coils acting like springs at low strains or stochastically un-
folding at large strains,53 while lateral fiber pulling also emphasized 
the importance of the unfolding of the αC- region,63 especially at 
low strains.70 Above 100% strain, the 22.5 nm monomer length in-
creased slightly, and the spatial order decreased.54 Fibers likely start 
to stiffen above 100% strain and thus distribute stress in the net-
work. In agreement with this, individual fibers were shown to redis-
tribute strain in the network above 100% strain65 as a consequence 
of individual fiber stiffening (seen from decreasing strain increment 
of the stretched fiber).
When crosslinked by factor XIII, clots show increased rigidi-
ty,77- 80 increasing linearly with the number of crosslinks.81 In agree-
ment with this, individual fibrin fibers also became stiffer when 
crosslinked,66 even if activated factor XIII was added later to al-
ready formed uncrosslinked and mechanically manipulated fibers.63 
Uncrosslinked fibers extend 2– 3- times their original length, whereas 
crosslinked fibers typically have lower extensibility.62,66 An earlier 
study showed higher extensibility for crosslinked fibers,45 which 
was later explained by the possibility that fibers were not fully 
crosslinked.66
3.3  |  Rupture
The unique mechanical behavior of fibrin protects against rupture at 
many levels. First, due to the elastic deformation at low strains and 
low stresses, the structure can adapt to external loads while main-
taining its structural integrity. Second, the structure can adapt to 
larger loads due to strain stiffening. In addition, as a consequence of 
strain stiffening, local strain is distributed throughout the network 
and protects against rupture.65 Moreover, bonds were reported to 
form between adjacent fibrin fibers upon moderate strains, possibly 
leading to plastic remodeling of the fibrin network.82 However, het-
erogeneities in the secondary structure were already present at 56% 
vertical strain,74 which suggests that some fibers are heavily loaded 
and thus prone to rupture.
In agreement with this, a recent study of crack propagation in 
clots found that clot rupture does not involve diffuse damage, but 
rather the propagation of a ‘critical flaw’ in the network structure, 
where fibers break when experiencing a critical stretch ahead of 
the crack.83 Thus, rupture happens at points of weakness or load 
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concentration and the high extensibility of individual fibers likely 
plays an important role against clot rupture. In individual fiber pull-
ing experiments, all parameters like stiffness, rupture stress and rup-
ture strain have an impact on the mechanical integrity of the fibers. 
Toughness, or the area under the stress- strain curve, which indicates 
the energy needed to rupture a fiber, could be an important param-
eter for future studies on the mechanical stability of the individual 
fibers.
It is important to note that viscoelastic properties of individual 
fibrin fibers, such as (non- linear) stiffness, cannot be directly re-
lated to the rupture properties. While stiffness is an inherent mate-
rial property, rupture is a specific event on the stress- strain curve. 
However, recent studies from our lab showed associations between 
decreased average clot (and fiber) stiffness and increased occur-
rence of clot rupture.55,84 The association between these properties 
requires further investigation.
4  |  CLINIC AL IMPLIC ATIONS OF FIBRIN 
MECHANIC S
The importance of fibrin biomechanical properties for hemostasis 
and thrombosis can be easily understood from the remarkable elastic 
properties that fibrin fibers and clots possess. Fibrin is one of the most 
elastic and extensible biological polymers known in nature, and has 
been compared with other elastic biological polymers.45 As with every 
other biological polymer, fibrin also displays viscous characteristics 
(i.e. is visco- elastic), which is also an important behavior as it means it 
can deform and absorb energy under impact.85 But elasticity generally 
outweighs its viscous nature and is crucially important for hemosta-
sis and thrombosis. During hemostasis, the fibrin clot functions as a 
temporary extracellular matrix when blood clots temporarily replace 
injured tissue. Clots sealing injury sites will be stretched upon move-
ment, and thus it is clear that elasticity (the ability to return to original 
shape upon deformation) is critically important.
Also, in the setting of thrombosis or the occlusion of a major 
blood vessel due to vessel injury or blood stasis, the visco- elastic 
properties of fibrin likely play an important role. Visualize thrombi 
in deep veins of the legs, which are subjected to movement of the 
leg muscles.86 There is a risk that parts of the clot may break off 
and lodge themselves in another blood vessel downstream, causing 
a blockage and tissue ischemia of a critical organ (e.g. the lungs). A 
similar situation occurs with clots that generate in the atrium due to 
arrythmia, or in the carotid artery due to local atherosclerosis, which 
may embolize to clot fragments occluding major brain blood vessels 
causing a stroke.87 While as discussed above fibrin fiber breakage 
and thus clot rupture is not directly linked to fibrin elasticity, it is 
clear that fibrin biomechanical properties must be critical to prevent 
such events from happening.
Despite such clear plausible mechanistic connections between 
fibrin visco- elastic characteristics and thrombosis or hemostasis, 
relatively little is known about the topic. There are some studies 
using TEG or ROTEM in patients with thrombosis, but many of these 
are in the surgical setting and have been reviewed elsewhere.88- 90 
Furthermore, thromboelastometry is limited by the relative arbitrary 
units as discussed above. We will therefore not discuss these pa-
pers further and instead focus on those studies that have provided 
more detailed analysis of the biophysical mechanical properties. In 
this regard, we are only beginning to understand how fibrin biome-
chanical characteristics may associate with or impact on thrombo-
embolic diseases. Clots from patients with coronary artery disease 
were highly branched and showed increased stiffness.91 Fibrin clots 
from patients with deep vein thrombosis and pulmonary embolism 
(PE) developed G' and G" upon blood clotting quicker, had reduced 
fibrin fiber density and increased susceptibility to fibrinolysis com-
pared with patients with deep vein thrombosis only.92 These find-
ings suggest a role for fibrinolysis and biomechanical fibrin stability 
in thromboembolic disease. Another study using lateral force AFM 
spectroscopy found no difference in visco- elastic properties of fi-
brin fibers in 5 patients with diabetes and poor glycemic control 
compared to 5 patients with optimal glycemic control or 4 healthy 
individuals.93 These findings are surprising as diabetes is known to 
increase the risk of thromboembolic disorders,94 and is also known 
to impact on clot structure.95,96 However, this lateral force AFM 
study was limited by a small number of patients and the experimen-
tal error could be relatively large. Interestingly, an association be-
tween thin fibers and increased stiffness was observed, suggesting 
that thin fibrin fibers are more densely packed than thick fibers.93
Recent studies from our lab showed two key new findings. The 
first is that fibrin clots from patients with recurrent venous throm-
boembolism showed reduced storage (elastic) moduli, thus were less 
stiff as analyzed in microrheology experiments using magnetic twee-
zers, compared with patients that had only one event, indicating that 
reduced elasticity may increase the risk of thromboembolism recur-
rence.55 These differences were observed without changes in factor 
XIII or fibrinogen levels or significant changes in clot structure, sug-
gesting that other mechanisms could determine clot elasticity. More 
recently we investigated the role of fibrin cross- linking by activated 
factor XIII in fibrin fiber stiffness, fiber strength and clot fragmen-
tation in a novel murine model of pulmonary embolism using X- ray 
and fluorescence imaging, combined with light sheet microscopy of 
the lungs. We found a 40% increase in pulmonary embolism in a new 
genetically modified murine model where we deleted the fibrinogen 
γ- chain cross- linking sites for activated factor XIII, compared with 
wildtype control.84 We also found that fibrin fibers of the γ- chain 
mutant ruptured at 40% less stress by lateral force AFM spectros-
copy than wildtype control. These findings demonstrate a key role 
of fibrin γ- chain cross- linking in maintaining fiber integrity and re-
covery under strain, with consequences for fragmentation of venous 
clots and subsequent pulmonary embolism84
5  |  CONCLUDING REMARKS
Fibrin demonstrates unique biomechanical properties that are key for 
its main function, i.e. the stemming of bleeds, while also impacting on 
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thrombosis and thromboembolism. We have learned that fibrin rheologi-
cal properties are determined by characteristics of the protein itself, the 
manner in which protofibrils are packed into individual fibers, and the 
structural properties of the fiber network. Any changes to the protein, 
fibers and network may have critical impact on the biomechanical prop-
erties of fibrin. We have also learned that the elastic properties and the 
resistance of fibers to rupture and clots to fragmentation are important 
properties for the prevention of thromboembolic disorders such as pul-
monary embolism and likely ischemic stroke. Fibrin γ- chain crosslinking 
by activated factor XIII appears indispensable in this regard.
Several open questions remain, however. With the improve-
ment of resolution in many techniques (high resolution AFM,97 
cryo- electron microscopy, super- resolution microscopies), we are 
beginning to understand processes of early formation of fibrin 
(proto)fibers and how these early events determine structural and 
mechanical properties of clots. The protofibril arrangements and 
packing inside individual fibrin fibers are a good working model, but 
the precise structural arrangements and how they impact on fibrin 
biomechanics is still not fully understood. The Y- ladder model and 
the catch- slip behavior of the A:a knob- hole bonds can add further 
interesting perspectives to our recent understanding. The molecular 
and structural basis of the unique mechanical properties of fibrin, 
i.e. the remarkable extensibility, more than 3 times its original length 
and strain stiffening behavior is yet to be fully deciphered. Partially 
truncated fibrin variants can be great tools to further elucidate such 
mechanisms in the future. Future studies need to establish optimal 
visco- elastic properties of fibrin that are able to stem bleeding yet 
reduce the risk of thromboembolism. Clinical studies are needed to 
study associations between clot biomechanical properties, bleeding, 
thrombosis and thromboembolism. Further studies are required to 
treat thrombosis by reducing clotting and clot size, while maintain-
ing clot stability and resistance to embolism during treatment. While 
substantial progress has thus far been made, these are some of the 
important future challenges in thrombosis and hemostasis research 
related to fibrin biology and biomechanics.
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